ALLIANCE PHARMA PLCALLIANCE PHARMA PLCALLIANCE PHARMA PLC

ALLIANCE PHARMA PLC

No trades
See on Supercharts
Next report date
Report period
H2 2023
EPS estimate
0.03EUR
Revenue estimate
‪114.64 M‬EUR
Market capitalization
‪220.23 M‬EUR
‪1.06 M‬EUR
‪189.18 M‬EUR
‪401.11 M‬
Beta (1Y)
1.67

About ALLIANCE PHARMA PLC

CEO
Peter Jonathan Butterfield
Headquarters
Chippenham
Employees (FY)
285
Founded
2001
ISIN
GB0031030819
FIGI
BBG000QY2TM6
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. It holds marketing rights to a range of healthcare brands and prescription medicines. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange ALLIANCE PHARMA PLC stocks are traded under the ticker DVL.
ALLIANCE PHARMA PLC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
DVL earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.03 EUR resulting in a 14.40% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about ALLIANCE PHARMA PLC earnings.
ALLIANCE PHARMA PLC revenue for the last quarter amounts to ‪91.47 M‬ EUR despite the estimated figure of ‪94.77 M‬ EUR. In the next quarter revenue is expected to reach ‪102.27 M‬ EUR.
Yes, you can track ALLIANCE PHARMA PLC financials in yearly and quarterly reports right on TradingView.
ALLIANCE PHARMA PLC dividend yield was 3.35% in 2022, and payout ratio reached ‪1.04 K‬%. The year before the numbers were 1.55% and 123.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, DVL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIANCE PHARMA PLC stock right from TradingView charts — choose your broker and connect to your account.
DVL reached its all-time high on Dec 29, 2021 with the price of 1.3100 EUR, and its all-time low was 0.1740 EUR and was reached on Nov 21, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 285.00 employees. See our rating of the largest employees — is ALLIANCE PHARMA PLC on this list?
We've gathered analysts' opinions on ALLIANCE PHARMA PLC future price: according to them, DVL price has a max estimate of 1.17 EUR and a min estimate of 0.49 EUR. Read a more detailed ALLIANCE PHARMA PLC forecast: see what analysts think of ALLIANCE PHARMA PLC and suggest that you do with its stocks.